LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • RBC Capital Markets Is Increasing Regeneron Pharmaceuticals (REGN) Q4 13 Estimate To 1.18 From 1.02 4/17/2013 9:23:04 AM
  • RBC Capital Markets Is Lowering Regeneron Pharmaceuticals (REGN) 2Q 13 Estimate To 0.97 From 0.98 4/17/2013 9:22:34 AM
  • RBC Capital Markets Is Raising Regeneron Pharmaceuticals (REGN) Q1 13 Estimate To 0.75 From 0.73 4/17/2013 9:22:13 AM
  • RBC Capital Markets Is Raising Regeneron Pharmaceuticals (REGN) FY 14 Estimate To 6.55 From 5.34 4/17/2013 9:21:40 AM
  • RBC Capital Markets Is Raising Regeneron Pharmaceuticals (REGN) FY 13 Estimate To 3.78 From 3.60 4/17/2013 9:21:15 AM
  • Barclays Capital Reiterates Regeneron Pharmaceuticals (REGN) At Overweight With $194 Price Target 4/3/2013 12:23:01 PM
  • Barclays Capital Starts Regeneron Pharmaceuticals (REGN) At Overweight With $194 Price Target 2/28/2013 12:31:51 PM
  • Robert W. Baird Reiterates Regeneron Pharmaceuticals (REGN) At Outperform With $205 Price Target 1/25/2013 7:37:10 AM
  • RBC Capital Markets Is Increasing Regeneron Pharmaceuticals (REGN) 4Q12 Estimate To 1.12 From 1.11 1/4/2013 9:26:03 AM
  • RBC Capital Markets Is Increasing Regeneron Pharmaceuticals (REGN) FY12 Estimate To 3.69 From 3.67 1/4/2013 9:25:36 AM
  • RBC Capital Markets Is Increasing Regeneron Pharmaceuticals (REGN) 4Q12 Rev. Estimate To 412.1 M From 410.1 M 1/4/2013 9:25:10 AM
  • RBC Capital Markets Is Increasing Regeneron Pharmaceuticals (REGN) FY12 Rev. Estimate To 1.376 Billion From 1.374 Billion 1/4/2013 9:24:31 AM
  • RBC Capital Markets Is Raising Regeneron Pharmaceuticals (REGN) FY13 Rev. Estimate To 1.960 Billion From 1.922 Billion 12/21/2012 10:05:18 AM
  • RBC Capital Markets Is Raising Regeneron Pharmaceuticals (REGN) FY13 Estimate To 4.00 From 3.83 12/21/2012 10:04:37 AM
  • Robert W. Baird Reiterates Regeneron Pharmaceuticals (REGN) At Outperform With $176 Price Target 11/12/2012 8:31:33 AM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap